DVAX (Dynavax Technologies Corporation)

Insider Trading Activity

Every open-market purchase and sale reported by DVAX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
1
code P
Sales
3
code S
Reporting Insiders
25
current holders
DVAX — Recent Form 4 Transactions (latest 2026-02-11)
FiledInsiderRole TypeSharesValue
2026-02-11 Deep Track Biotechnology Master Fund, Ltd. 10%+ Owner U
2026-02-10 Emilio Emini Director D
2026-02-10 Scott Dunseth Myers Director MIXED
2026-02-10 Joseph Anthony Metzinger VP, Chief Accounting Officer U
2026-02-10 David F Novack President & COO MIXED
2026-02-10 LAUREN P SILVERNAIL Director D
2026-02-10 Elaine D Sun Director D
2026-02-10 Ryan Spencer CEO and Director MIXED
2026-02-10 DANIEL L KISNER Director MIXED
2026-02-10 Brent MacGregor Director D
2026-02-10 FRANCIS CANO Director D
2026-02-10 John L Slebir SVP General Counsel MIXED
2026-02-10 Kelly MacDonald SVP and CFO MIXED
2026-01-20 David F Novack President & COO MIXED
2025-12-29 John L Slebir SVP General Counsel MIXED
2025-12-29 Joseph Anthony Metzinger VP, Chief Accounting Officer MIXED
2025-12-29 Ryan Spencer CEO and Director MIXED
2025-12-29 David F Novack President & COO MIXED
2025-12-29 Kelly MacDonald SVP and CFO MIXED
2025-08-25 Scott Dunseth Myers Director Buy
2025-08-22 Deep Track Biotechnology Master Fund, Ltd. 10%+ Owner Sell
2025-06-13 Peter R. Paradiso Director A
2025-06-13 DANIEL L KISNER Director A
2025-06-13 Emilio Emini Director A
2025-06-13 Elaine D Sun Director A
2025-06-13 LAUREN P SILVERNAIL Director A
2025-06-13 Scott Dunseth Myers Director A
2025-06-13 Brent MacGregor Director A
2025-06-13 FRANCIS CANO Director A
2025-05-13 Joseph Anthony Metzinger VP, Chief Accounting Officer A
2025-03-26 David F Novack President & COO MIXED
2025-03-20 David F Novack President & COO Sell
2025-03-10 David F Novack President & COO Sell
2025-02-21 John L Slebir SVP General Counsel MIXED
2025-02-20 Ryan Spencer CEO and Director MIXED
2025-02-20 Robert Janssen SVP and CMO MIXED
2025-02-20 Kelly MacDonald SVP and CFO MIXED
2025-02-20 David F Novack President & COO MIXED
2025-02-18 Robert Janssen SVP and CMO MIXED
2025-02-18 David F Novack President & COO MIXED
2025-02-18 John L Slebir SVP General Counsel MIXED
2025-02-18 Kelly MacDonald SVP and CFO MIXED
2025-02-18 Ryan Spencer CEO and Director MIXED
2025-02-12 Kelly MacDonald SVP and CFO MIXED
2025-02-12 Justin Burgess VP Finance & CAO MIXED
2025-02-12 Ryan Spencer CEO and Director MIXED
2025-02-12 John L Slebir SVP General Counsel MIXED
2025-02-12 Robert Janssen SVP and CMO MIXED
2025-02-12 David F Novack President & COO MIXED
2025-02-05 Emilio Emini Director A
DVAX — Current Insider Holders
InsiderRole Shares HeldValue
10%+ Owner 1,179,292
1,098,392
Director 925,714
Director 903,143
10%+ Owner 855,770
CEO and Director 304,597
Director 303,143
CEO and Director 136,000
Senior Vice President 134,752
SVP and CMO 81,526
Senior Vice President 77,768
CEO and Director 69,898
Vice President 63,259
Director 43,804
Director 37,506
Director 24,829
President, CMO & Director 22,209
Director 16,071
Director 15,624
VP, Global Technical Ops 10,615
VP Finance & CAO 6,666
VP, Finance & PAO 2,108
Director 1,500
Director 1,000
Director 500
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the DVAX quote page; the site-wide leaderboard is on the insider transactions hub.